IJT - CIR - February 2024 - 79S

Burnett et al.
79S
Author Contributions
The articles in this supplement were sponsored by the Cosmetic
Ingredient Review.
Declaration of conflicting interests
The author(s) declared the following potential conflicts of interest
with respect to the research, authorship, and/or publication of this
article: Cosmetic Ingredient Review.
Funding
The author(s) disclosed receipt of the following financial support for
the research, authorship, and/or publication of this article: This work
was supported by the articles in this supplement were sponsored by
the Cosmetic Ingredient Review. The Cosmetic Ingredient Review is
financially supported by the Personal Care Products Council.
References
1. Nikitakis J, Lange B. wINCI: International Cosmetic Ingredient
Dictionary and Handbook. Washington, DC; 2017. http://
webdictionary.personalcarecouncil.org/jsp/Home.jsp. Last Updated
2017. Date Accessed 7-10-2017
2. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients
Used in Food, Drugs, and Cosmetics. 2nd edn. New
York: John Wiley and Sons, Inc; 1996.
3. Thomson Healthcare. PDR for Herbal Medicines. 4th edn.
Montvale, NJ: Thomson Reuters; 2007:371-384.
4. van Beek TA, Montoro P. Chemical analysis and quality control
of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
J Chromatogr A. 2009;1216:2002-2032.
5. Sch¨otz K. Quantification of allergenic urushiols in extracts of
Ginkgo biloba leaves, in simple one-step extracts and refined
manufactured material (EGb 761). Phytochem Anal. 2004;15:
1-8.
6. Anonymous. Summary information Ginkgo Biloba LeafExtract.
Unpublished data submitted by Personal Care Products Council;
2017.
7. Anonymous. Ginkgo Biloba Meristem Cell: Method of
Manufacturing. Unpublished data submitted by Personal
Care Products Counci; 2017.
8. Spec-Chem Industry Inc. Certificate of analysis SpecPure™
GBE (Ginkgo Biloba LeafExtract). Unpublished data submitted
by Personal Care Products Council; 2017.
9. National Toxicology Program (NTP) U.S. Department ofhealth
and human services. NTP Technical Report of the Toxicology
and Carcinogenesis Studies ofGinkgo Biloba Extract (CAS No.
90045-36-6) in F344/N Rats and B6C3F1/N Mice (Gavage
Studies). National Institutes of Health, Public Health Service.
2013. https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr578_508.
pdf. Date Accessed 8-22-2017. Report No. NTP TR 578.
NIH Publication No. 13-5920
10. Lobstein A, Rietsch-Jako L, Haag-Berrurier M, et al. Seasonal
variations of the flavonoid content from Ginkgo biloba leaves.
Planta Med. 1991;57(5):430-433.
11. U.S. Pharmacopeial Convention. U.S. Pharamcopeia-National
Formulary [USP 32 NF27]. Rockville, MD: The United States
Phamacopeial Convention, 2009.
12. British Pharmacopoeia Commissio. British Pharmacopoeia.
London: The Stationery Office, 2008.
13. Koch E, Jaggy H, Chatterjee SS. Evidence for immunotoxic
effects ofcrude Ginkgo biloba L. leafextracts using the popliteal
lymph node assay in the mouse. Int JImmunopharmacol. 2000;
22(3):229-236.
14. Blumenthal M, ed. The Complete German Commission E
Monographs: Therapeutic Guide to Herbal Medicines. Austin,
TX: The American Botanical Council; 1998.
15. Tomb RR, Foussereau J, Sell Y. Mini-epidemic of contact
dermatitis from ginkgo tree fruit (Ginkgo biloba L.). Contact
Dermatitis. 1988;19(4):281-283.
16. Anonymous. Ginkgo Biloba LeafExtract and Ginkgo Biloba Nut
Extract: Summary specification information. Unpublished data
submitted by Personal Care Products Council, 2018.
17. Anonymous. Chromatogram ofGinkgo Biloba Meristem Cell.Unpublished
data submitted by Personal Care Products Council, 2017.
18. Personal Care Products Council. Ginkgo Biloba Meristem Cell.
Unpublished data submitted by Personal Care Products Council,
2018.
19. Anonymous. Absorption spectra ofGinkgo Biloba LeafExtract.
Unpublished data submitted by Personal Care Products Council,
2018.
20. U.S. Food and Drug Administration Center for Food Safety &
Applied Nutrition (CFSAN). Voluntary Cosmetic Registration
Program - Frequency ofUse ofCosmetic Ingredients. College
Park, MD: 2018. Obtained under the Freedom ofInformation
Act from CFSAN; requested as " Frequency of Use Data "
January 3, 2018; received February 5, 2018.
21. Personal Care Products Council. Concentration ofUse by FDA
Product Category: Ginkgo Biloba Leaf Cell Extract. Unpublished
data submitted by Personal Care Products Council, 2018.
22. Personal Care Products Council. Updated Concentration ofUse
by FDA Product Category: Ginkgo Biloba-Derived Ingredients.
Unpublished data submitted by Personal Care Products Council,
2018.
23. Personal Care Products Council. Concentration of Use by FDA
Product Category: Ginkgo biloba-Derived Ingredients. Unpublished
data submitted by Personal Care Products Council.
24. Rothe H, Fautz R, Gerber E, et al. Special aspects of cosmetic
spray safety evaluations: Principles on inhalation risk assessment.
Toxicol Lett. 2011;205(2):97-104.
25. Rothe H. Special Aspects ofCosmetic Spray Evalulation. 9-262011.
Unpublished data presented at the 26 September CIR
Expert Panel meeting. Washington, DC.
26. Bremmer HJ, Prud'homme de Lodder LCH, Engelen JGM.
Cosmetics Fact Sheet: To assess the risks for the consumer;
Updated version for ConsExpo 4. Bilthoven, Netherlands:
Netherlands National Institute for Public Health and the Environment.
2006. http://www.rivm.nl/bibliotheek/rapporten/
320104001.pdf. Date Accessed 8-24-2011. Report No. RIVM
320104001/2006. pp. 1-77
http://webdictionary.personalcarecouncil.org/jsp/Home.jsp http://webdictionary.personalcarecouncil.org/jsp/Home.jsp https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr578_508.pdf https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr578_508.pdf http://www.rivm.nl/bibliotheek/rapporten/320104001.pdf http://www.rivm.nl/bibliotheek/rapporten/320104001.pdf

IJT - CIR - February 2024

Table of Contents for the Digital Edition of IJT - CIR - February 2024

Contents
IJT - CIR - February 2024 - Cover1
IJT - CIR - February 2024 - Cover2
IJT - CIR - February 2024 - 1S
IJT - CIR - February 2024 - 2S
IJT - CIR - February 2024 - Contents
IJT - CIR - February 2024 - 4S
IJT - CIR - February 2024 - 5S
IJT - CIR - February 2024 - 6S
IJT - CIR - February 2024 - 7S
IJT - CIR - February 2024 - 8S
IJT - CIR - February 2024 - 9S
IJT - CIR - February 2024 - 10S
IJT - CIR - February 2024 - 11S
IJT - CIR - February 2024 - 12S
IJT - CIR - February 2024 - 13S
IJT - CIR - February 2024 - 14S
IJT - CIR - February 2024 - 15S
IJT - CIR - February 2024 - 16S
IJT - CIR - February 2024 - 17S
IJT - CIR - February 2024 - 18S
IJT - CIR - February 2024 - 19S
IJT - CIR - February 2024 - 20S
IJT - CIR - February 2024 - 21S
IJT - CIR - February 2024 - 22S
IJT - CIR - February 2024 - 23S
IJT - CIR - February 2024 - 24S
IJT - CIR - February 2024 - 25S
IJT - CIR - February 2024 - 26S
IJT - CIR - February 2024 - 27S
IJT - CIR - February 2024 - 28S
IJT - CIR - February 2024 - 29S
IJT - CIR - February 2024 - 30S
IJT - CIR - February 2024 - 31S
IJT - CIR - February 2024 - 32S
IJT - CIR - February 2024 - 33S
IJT - CIR - February 2024 - 34S
IJT - CIR - February 2024 - 35S
IJT - CIR - February 2024 - 36S
IJT - CIR - February 2024 - 37S
IJT - CIR - February 2024 - 38S
IJT - CIR - February 2024 - 39S
IJT - CIR - February 2024 - 40S
IJT - CIR - February 2024 - 41S
IJT - CIR - February 2024 - 42S
IJT - CIR - February 2024 - 43S
IJT - CIR - February 2024 - 44S
IJT - CIR - February 2024 - 45S
IJT - CIR - February 2024 - 46S
IJT - CIR - February 2024 - 47S
IJT - CIR - February 2024 - 48S
IJT - CIR - February 2024 - 49S
IJT - CIR - February 2024 - 50S
IJT - CIR - February 2024 - 51S
IJT - CIR - February 2024 - 52S
IJT - CIR - February 2024 - 53S
IJT - CIR - February 2024 - 54S
IJT - CIR - February 2024 - 55S
IJT - CIR - February 2024 - 56S
IJT - CIR - February 2024 - 57S
IJT - CIR - February 2024 - 58S
IJT - CIR - February 2024 - 59S
IJT - CIR - February 2024 - 60S
IJT - CIR - February 2024 - 61S
IJT - CIR - February 2024 - 62S
IJT - CIR - February 2024 - 63S
IJT - CIR - February 2024 - 64S
IJT - CIR - February 2024 - 65S
IJT - CIR - February 2024 - 66S
IJT - CIR - February 2024 - 67S
IJT - CIR - February 2024 - 68S
IJT - CIR - February 2024 - 69S
IJT - CIR - February 2024 - 70S
IJT - CIR - February 2024 - 71S
IJT - CIR - February 2024 - 72S
IJT - CIR - February 2024 - 73S
IJT - CIR - February 2024 - 74S
IJT - CIR - February 2024 - 75S
IJT - CIR - February 2024 - 76S
IJT - CIR - February 2024 - 77S
IJT - CIR - February 2024 - 78S
IJT - CIR - February 2024 - 79S
IJT - CIR - February 2024 - 80S
IJT - CIR - February 2024 - 81S
IJT - CIR - February 2024 - 82S
IJT - CIR - February 2024 - 83S
IJT - CIR - February 2024 - 84S
IJT - CIR - February 2024 - 85S
IJT - CIR - February 2024 - 86S
IJT - CIR - February 2024 - 87S
IJT - CIR - February 2024 - 88S
IJT - CIR - February 2024 - 89S
IJT - CIR - February 2024 - 90S
IJT - CIR - February 2024 - 91S
IJT - CIR - February 2024 - 92S
IJT - CIR - February 2024 - 93S
IJT - CIR - February 2024 - 94S
IJT - CIR - February 2024 - 95S
IJT - CIR - February 2024 - 96S
IJT - CIR - February 2024 - 97S
IJT - CIR - February 2024 - 98S
IJT - CIR - February 2024 - 99S
IJT - CIR - February 2024 - 100S
IJT - CIR - February 2024 - 101S
IJT - CIR - February 2024 - 102S
IJT - CIR - February 2024 - 103S
IJT - CIR - February 2024 - 104S
IJT - CIR - February 2024 - 105S
IJT - CIR - February 2024 - 106S
IJT - CIR - February 2024 - 107S
IJT - CIR - February 2024 - 108S
IJT - CIR - February 2024 - 109S
IJT - CIR - February 2024 - 110S
IJT - CIR - February 2024 - 111S
IJT - CIR - February 2024 - 112S
IJT - CIR - February 2024 - 113S
IJT - CIR - February 2024 - 114S
IJT - CIR - February 2024 - 115S
IJT - CIR - February 2024 - 116S
IJT - CIR - February 2024 - 117S
IJT - CIR - February 2024 - 118S
IJT - CIR - February 2024 - Cover3
IJT - CIR - February 2024 - Cover4
https://www.nxtbookmedia.com